Literature DB >> 30410831

Gustatory Rhinorrhea: A Rare Presentation of Parkinson's Disease.

Ujala Zubair1, Osama Salam2, Zarafshan Zubair3.   

Abstract

Non-motor symptoms appear earlier than the motor symptoms of Parkinson's disease. Gustatory rhinorrhea is a rare presentation of Parkinson's disease. We report a case of 70-year-old male who presented to the outpatient department (OPD) with watery secretions on thought or site of food. Symptomatic treatment was advised along with many investigations for the cause. Twenty-two months later the patient developed fine tremors of hands which were evident of Parkinson's disease.

Entities:  

Keywords:  gustatory rhinorrhea; parkinson's disease; rare presentations

Year:  2018        PMID: 30410831      PMCID: PMC6207285          DOI: 10.7759/cureus.3224

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Parkinson’s disease is a neurodegenerative disorder affecting the autonomic, limbic and somatomotor system and later involving the dopaminergic neurons of mid-brain and substantia nigra. The four most common pathways suffering damage in Parkinson's disease include the mesocortical, mesolimbic, tubero-infundibular and nigrostriatal pathways. These pathways are also involved in several non-motor functions [1,2]. Non-motor features of Parkinson's disease include hypotension, urinary incontinence, erectile dysfunction, anosmia, constipation, depression, sleep disorders and fatigue. These symptoms are rarely used for the diagnosis of Parkinson disease at an early stage [3]. Few studies have suggested that Parkinson disease pathology begins from extra-nigral structures such as olfactory bulb, brain stem nuclei and sympathetic plexus usually gastric myenteric plexus rather than substantia nigra pars compacta [1]. Some researchers have recommended that sympathetic denervation of the nasal mucosa is found in Parkinson’s disease patients which is followed by unopposed parasympathetic stimulation which explains dribbling of watery secretions. Sympathetic denervation followed by unopposed parasympathetic denervation is also found in heart among patients with Parkinson’s disease [4,5].

Case presentation

We report a case of a 70-year-old male patient who presented to the outpatient department (OPD) with chief complain of dribbling of watery secretions from nasal mucosa on the thought of food or sight of food. Each episode of dribbling comprised of secretion of 50–100 ml of watery fluid. Past medical history was significant for hypertension for three years and type 2 diabetes mellitus for five years. There was no history of any neuro-degenerative disease in the family. Furthermore, there was a history of constipation for three months along with the presence of mucus in stool. Colonoscopy was performed which showed no significant pathology. There was no evidence of dementia or other psychiatric disturbances. Mild sleep abnormalities were present. Forward flex posture was present along with broad-based gait. A mask-like face was not present. A provisional diagnosis of gustatory rhinorrhea was made and the patient was advised of anti-cholinergic medications and anti-histamine drugs. There was little to no benefit with these medications. The patient was further prescribed with nasal corticosteroid sprays, mucolytic medications, and nasal irrigations but these prescriptions only provided mild symptomatic improvement. Twenty-two months later, the patient presented again in the OPD and had developed fine tremors in fingers and hands. These tremors were absent in head and lower limbs. Tremors were only evident at rest while absent on activity. Further examination revealed an altered sense of smell which was un-noticed by the patient. The patient was diagnosed with Parkinson’s disease. Dopamine-based therapy was commenced which resulted in improvement of rhinorrhea as well as motor symptoms.

Discussion

In our patient, early diagnosis of Parkinson’s disease would have prevented the delay in commencement of neuro-protective strategies. There is a 2% chance of an individual over the age of 50 years to develop Parkinson’s disease. If family history is positive for Parkinson’s disease, the chance doubles to 4% [6]. There can be difficulties in diagnosis of Parkinson’s disease. Some common differentials can be Alzheimer’s disease, Lewy body dementia, and essential tremor. Around 25% cases are clinically misdiagnosed as Parkinson’s disease [7]. The response to dopamine therapy is the only confirmatory sign for correct diagnosis. However, some diagnostic studies have been used to diagnose and treat Parkinson’s disease at an early stage. These include genetic testing, neuroimaging, autonomic function testing studies and dopamine challenge testing [7]. Some recent studies have identified the role of transcranial sonography and 123I-B-SPECT (Single-photon emission computed tomography) in diagnosing Parkinson’s disease at the earliest possible stage [3]. Neuronal loss involving nigrostriatal neurons progresses up to 40% before the initial appearance of motor signs. In contrast to which non-motor symptoms appear early and can provide clues to early diagnosis [8,9]. The appearance of motor signs is further delayed by the compensatory mechanisms which delay the appearance of motor signs by counter-acting the striatal neuronal loss [10,11]. Chou et al. have concluded in their study that among Parkinson’s disease patients, rhinorrhea due to any cause is not related to the severity of nigrostriatal dysfunction [12]. The correlation among rhinorrhea, autonomic dysfunction, and sympathetic denervation needs further research which could help in understanding the underlying pathophysiologic mechanisms.

Conclusions

Some motor tests can be important in early screening for Parkinson’s disease. In case of positive screening results, further imaging studies such as DAT imaging (a dopamine transporter single photon emission computerized tomography imaging technique) can be carried out for final diagnosis. Rare presentations should be kept in mind while examining high risk individuals.
  12 in total

1.  Risk tables for parkinsonism and Parkinson's disease.

Authors:  Alexis Elbaz; James H Bower; Demetrius M Maraganore; Shannon K McDonnell; Brett J Peterson; J Eric Ahlskog; Daniel J Schaid; Walter A Rocca
Journal:  J Clin Epidemiol       Date:  2002-01       Impact factor: 6.437

2.  Rhinorrhea and olfaction in Parkinson disease.

Authors:  Joseph H Friedman; Melissa M Amick; Kelvin L Chou
Journal:  Neurology       Date:  2008-02-05       Impact factor: 9.910

Review 3.  The diagnosis of Parkinson's disease.

Authors:  Eduardo Tolosa; Gregor Wenning; Werner Poewe
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

Review 4.  Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.

Authors:  Bart F L van Nuenen; Thilo van Eimeren; Joyce P M van der Vegt; Carsten Buhmann; Christine Klein; Bastiaan R Bloem; Hartwig R Siebner
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

Review 5.  Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.

Authors:  Erwan Bezard; Christian E Gross; Jonathan M Brotchie
Journal:  Trends Neurosci       Date:  2003-04       Impact factor: 13.837

6.  Rhinorrhea: a common nondopaminergic feature of Parkinson's disease.

Authors:  Kelvin L Chou; Robert A Koeppe; Nicolaas I Bohnen
Journal:  Mov Disord       Date:  2010-09-14       Impact factor: 10.338

7.  Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

Authors:  Sandrine Greffard; Marc Verny; Anne-Marie Bonnet; Jean-Yves Beinis; Claude Gallinari; Sylvie Meaume; François Piette; Jean-Jacques Hauw; Charles Duyckaerts
Journal:  Arch Neurol       Date:  2006-04

Review 8.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

9.  Ageing and Parkinson's disease: substantia nigra regional selectivity.

Authors:  J M Fearnley; A J Lees
Journal:  Brain       Date:  1991-10       Impact factor: 13.501

10.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Authors:  Anette Schrag; Laura Horsfall; Kate Walters; Alastair Noyce; Irene Petersen
Journal:  Lancet Neurol       Date:  2014-11-27       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.